Catalio Capital

Type

Private equity, Loans/Credit

Status

Active

Location

New York, United States

Total investments

62

Average round size

66M

Portfolio companies

46

Rounds per year

7.75

Lead investments

7

Follow on index

0.24

Exits

2

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Investor highlights

Industry focus
Biotech/Life SciencesMedtechHealthcare
Stage focus
Generalist
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 381000000
Fund raised date
2022-05-03

Analytics

Total investments
62
Lead investments
7
Exits
2
Rounds per year
7.75
Follow on index
0.24
Investments by industry
  • Biotechnology (46)
  • Health Care (34)
  • Life Science (21)
  • Therapeutics (19)
  • Medical (13)
  • Show 22 more
Investments by region
  • United States (53)
  • Germany (4)
  • France (1)
  • Israel (1)
  • Switzerland (1)
Peak activity year
2022
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
65M
Group Appearance index
0.97
Avg. company exit year
2
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Metagenomi 05 Jan 2023 Artificial Intelligence, Machine Learning Early Stage Venture 100M United States, California
PinkDx 25 Apr 2024 Biotechnology, Biopharma Early Stage Venture 40M United States, Indianapolis, Indiana

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.